Provides a duty upon midwives, physician assistants and nurse practitioners to obtain a blood specimen of pregnant women within thirty (30) days after the first professional visit.
Summary
H5613 amends Rhode Island’s sexually transmitted diseases law to require blood testing for syphilis during pregnancy by expanding who is responsible for obtaining the specimen. Under current law, physicians and certain other prenatal providers must obtain a blood specimen from a pregnant woman within 30 days of the first professional visit and again during the third trimester; this bill adds midwives, physician assistants, and nurse practitioners to that duty. The bill keeps the existing testing framework, requiring submission to the state health department or an approved laboratory for a standard syphilis test.
The measure is a public health and prenatal care bill aimed at ensuring consistent screening for syphilis during pregnancy, which can help prevent congenital syphilis and related complications. It takes effect upon passage and does not create a new testing program so much as broaden the list of licensed providers responsible for carrying out an existing requirement.
Impact
The bill amends Section 23-11-8 of the Rhode Island General Laws, Chapter 23-11 on sexually transmitted diseases, by extending the statutory duty to obtain prenatal blood specimens to midwives, physician assistants, and nurse practitioners. It preserves the current timing of testing—within 30 days of the first prenatal visit and again in the third trimester—and the existing laboratory submission requirements. The practical effect is to impose a legal compliance obligation on additional prenatal care providers and reinforce state-mandated syphilis screening for pregnant patients.
Sentiment
The available voting record shows strong support for the bill: it passed the House 68-0 on April 8, 2025. No committee transcript excerpts were provided, and there is no indication of organized opposition in the materials supplied. The unanimous vote suggests broad agreement that the bill is a routine public health measure and an administrative update to existing prenatal screening law.
Contention
No specific points of contention are evident in the provided record. The only likely policy issue is the expansion of legal responsibility from physicians to midwives, physician assistants, and nurse practitioners, which could raise implementation or compliance concerns for those providers. However, the unanimous floor vote indicates that any such concerns did not generate visible opposition in the House.